G  ||| S:0 E:2 ||| NNP
protein  ||| S:2 E:10 ||| NN
regulation  ||| S:10 E:21 ||| NN
of  ||| S:21 E:24 ||| IN
neuronal  ||| S:24 E:33 ||| JJ
calcium  ||| S:33 E:41 ||| NN
channels ||| S:41 E:49 ||| NNS
:  ||| S:49 E:51 ||| :
back  ||| S:51 E:56 ||| RB
to  ||| S:56 E:59 ||| TO
the  ||| S:59 E:63 ||| DT
future  ||| S:63 E:70 ||| JJ
Neuronal  ||| S:70 E:79 ||| JJ
voltage-gated  ||| S:79 E:93 ||| JJ
calcium  ||| S:93 E:101 ||| NN
channels  ||| S:101 E:110 ||| NNS
have  ||| S:110 E:115 ||| VBP
evolved  ||| S:115 E:123 ||| VBN
as  ||| S:123 E:126 ||| IN
one  ||| S:126 E:130 ||| CD
of  ||| S:130 E:133 ||| IN
the  ||| S:133 E:137 ||| DT
most  ||| S:137 E:142 ||| RBS
important  ||| S:142 E:152 ||| JJ
players  ||| S:152 E:160 ||| NNS
for  ||| S:160 E:164 ||| IN
calcium  ||| S:164 E:172 ||| JJ
entry  ||| S:172 E:178 ||| NN
into  ||| S:178 E:183 ||| IN
presynaptic  ||| S:183 E:195 ||| JJ
endings  ||| S:195 E:203 ||| JJ
responsible  ||| S:203 E:215 ||| JJ
for  ||| S:215 E:219 ||| IN
the  ||| S:219 E:223 ||| DT
release  ||| S:223 E:231 ||| NN
of  ||| S:231 E:234 ||| IN
neurotransmitters ||| S:234 E:251 ||| NN
.  ||| S:251 E:253 ||| .
In  ||| S:253 E:256 ||| IN
turn ||| S:256 E:260 ||| NN
,  ||| S:260 E:262 ||| ,
and  ||| S:262 E:266 ||| CC
to  ||| S:266 E:269 ||| TO
fine-tune  ||| S:269 E:279 ||| JJ
synaptic  ||| S:279 E:288 ||| JJ
activity  ||| S:288 E:297 ||| NN
and  ||| S:297 E:301 ||| CC
neuronal  ||| S:301 E:310 ||| JJ
communication ||| S:310 E:323 ||| NN
,  ||| S:323 E:325 ||| ,
numerous  ||| S:325 E:334 ||| JJ
neurotransmitters  ||| S:334 E:352 ||| NNS
exert  ||| S:352 E:358 ||| VBP
a  ||| S:358 E:360 ||| DT
potent  ||| S:360 E:367 ||| JJ
negative  ||| S:367 E:376 ||| JJ
feedback  ||| S:376 E:385 ||| NN
over  ||| S:385 E:390 ||| IN
the  ||| S:390 E:394 ||| DT
calcium  ||| S:394 E:402 ||| JJ
signal  ||| S:402 E:409 ||| NN
provided  ||| S:409 E:418 ||| VBN
by  ||| S:418 E:421 ||| IN
G  ||| S:421 E:423 ||| NNP
protein-coupled  ||| S:423 E:439 ||| JJ
receptors ||| S:439 E:448 ||| NNS
.  ||| S:448 E:450 ||| .
This  ||| S:450 E:455 ||| DT
regulation  ||| S:455 E:466 ||| NN
pathway  ||| S:466 E:474 ||| NN
of  ||| S:474 E:477 ||| IN
physiologic  ||| S:477 E:489 ||| JJ
importance  ||| S:489 E:500 ||| NN
is  ||| S:500 E:503 ||| VBZ
also  ||| S:503 E:508 ||| RB
extensively  ||| S:508 E:520 ||| RB
exploited  ||| S:520 E:530 ||| VBN
for  ||| S:530 E:534 ||| IN
therapeutic  ||| S:534 E:546 ||| JJ
purposes ||| S:546 E:554 ||| NNS
,  ||| S:554 E:556 ||| ,
for  ||| S:556 E:560 ||| IN
instance  ||| S:560 E:569 ||| NN
in  ||| S:569 E:572 ||| IN
the  ||| S:572 E:576 ||| DT
treatment  ||| S:576 E:586 ||| NN
of  ||| S:586 E:589 ||| IN
neuropathic  ||| S:589 E:601 ||| JJ
pain  ||| S:601 E:606 ||| NN
by  ||| S:606 E:609 ||| IN
morphine  ||| S:609 E:618 ||| NN
and  ||| S:618 E:622 ||| CC
other  ||| S:622 E:628 ||| JJ
Î¼-opioid  ||| S:628 E:637 ||| JJ
receptor  ||| S:637 E:646 ||| NN
agonists ||| S:646 E:654 ||| NN
.  ||| S:654 E:656 ||| .
However ||| S:656 E:663 ||| RB
,  ||| S:663 E:665 ||| ,
despite  ||| S:665 E:673 ||| IN
more  ||| S:673 E:678 ||| JJR
than  ||| S:678 E:683 ||| IN
three  ||| S:683 E:689 ||| CD
decades  ||| S:689 E:697 ||| NNS
of  ||| S:697 E:700 ||| IN
intensive  ||| S:700 E:710 ||| JJ
research ||| S:710 E:718 ||| NN
,  ||| S:718 E:720 ||| ,
important  ||| S:720 E:730 ||| JJ
questions  ||| S:730 E:740 ||| NNS
remain  ||| S:740 E:747 ||| VBP
unsolved  ||| S:747 E:756 ||| VBN
regarding  ||| S:756 E:766 ||| VBG
the  ||| S:766 E:770 ||| DT
molecular  ||| S:770 E:780 ||| JJ
and  ||| S:780 E:784 ||| CC
cellular  ||| S:784 E:793 ||| JJ
mechanisms  ||| S:793 E:804 ||| NNS
of  ||| S:804 E:807 ||| IN
direct  ||| S:807 E:814 ||| JJ
G  ||| S:814 E:816 ||| NNP
protein  ||| S:816 E:824 ||| NN
inhibition  ||| S:824 E:835 ||| NN
of  ||| S:835 E:838 ||| IN
voltage-gated  ||| S:838 E:852 ||| JJ
calcium  ||| S:852 E:860 ||| NN
channels ||| S:860 E:868 ||| NNS
.  ||| S:868 E:870 ||| .
In  ||| S:870 E:873 ||| IN
this  ||| S:873 E:878 ||| DT
study ||| S:878 E:883 ||| NN
,  ||| S:883 E:885 ||| ,
we  ||| S:885 E:888 ||| PRP
revisit  ||| S:888 E:896 ||| VB
this  ||| S:896 E:901 ||| DT
particular  ||| S:901 E:912 ||| JJ
regulation  ||| S:912 E:923 ||| NN
and  ||| S:923 E:927 ||| CC
explore  ||| S:927 E:935 ||| VB
new  ||| S:935 E:939 ||| JJ
considerations ||| S:939 E:953 ||| NNS
.  ||| S:953 E:955 ||| .
